Understanding Addiction. Understanding Addiction. Acknowledgements. KP Regional Pain Symposium August 8, Mary Eno MD, MPH

Similar documents
Substance Use and Mental Health Disorders: Challenges for Primary Care

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Brain Stimulation in the Study and Treatment of Addiction. From Animal Models to Humans

Understanding Opioid Use Disorder and the Treatment Armamentarium

8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Pharmacotherapy for Substance Use Disorders

Treatment Team Approaches in Substance Abuse Treatment

Treatment Approaches for Drug Addiction

Addiction Medicine: What s new for primary care

Thaddeus Ulzen MD FRCP(C)FAPA FCGP Professor & Chair, Department of Psychiatry and Behavioral Medicine, Associate Dean for Academic Affairs

Alcoholism has been demonstrated to have a genetic component, especially among men.

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

ECHO Presentation Addiction & Brain Function

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Medical Management of Substance Use Disorders: Does research translate to clinical practice

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

The future of pharmacological treatment.

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

Discover the Hope: Opiate Treatment and Recovery

Medication-Assisted Treatment (MAT) Overview

America is a drugged society

The Importance of Psychological Treatment and Behavioral Support

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Dr. Renner receives honoraria from Reed Medical Education

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

The Chronic Disease of Addiction Evidence and Lessons from Practice

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Treatment Alternatives for Substance Use Disorders

Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical

NEUROBIOLOGY ALCOHOLISM

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Understanding Drug and Alcohol Abuse and Addiction

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS

Naltrexone protocol alcohol

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Neuroscience of Addiction

Treating Opioid Addiction

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph

Understanding Addiction: Why Can t Those Affected Just Say No?

Opiate Use Disorder and Opiate Overdose

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Opioids Research to Practice

Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations

Extended-Release Naltrexone for Opioid Relapse Prevention

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Topics of today s training

Medication Assisted Treatment as an alternative in Drug Courts*

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Substance Use Disorders: What Can We Do to Help Break the Cycle of Addiction

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Alcohol 2: Case Examples

Addictions Pharmacotherapy

Medication for Addiction Treatment (MAT)

Module II Opioids 101 Opiate Opioid

THE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.

2/21/2018. What are Opioids?

Health Systems and Addiction: Provider Issues

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Opioids Research to Practice

Understanding Addiction and Dugs Of Abuse

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

The Science of Drug Addiction: Implications for Clinical Practice

4/28/2016. You don t need to remember. ASAM Definition of Addiction. ASAM Definition

Psychopharmacology Practice Guidelines For Individuals With Co-Occurring Substance Abuse (SA) And Serious Mental Illness (SMI)

A MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

GOALS AND OBJECTIVES

11/3/2014. Opiates: methadone, buprenorphine, heroin, prescription drugs: Vicodin, OxyContin, Percocet

Neurobiology of addiction and why it is important

What is addiction and what can businesses do about it?

Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do?

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Unit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction

Methadone and Naltrexone ER

Treating Addiction as a Chronic Disease

Opioid Overdose Epidemic A Crises and Opportunity

Biological Addictions Treatment. Psychology 470. Many Types of Approaches

Opioid Use Disorder Treatment Initiation in Diverse Settings

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

NEW HAMPSHIRE ACADEMY OF FAMILY PRACTICE. May 19, 2019 Mountain View Grand

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine

THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved

Opioids and Opioid Addiction: Practical Management Approaches

Vivitrol/Suboxone. Comparison Study Summary

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

If you give any person a prescription of something like Valium and have them take it on

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Transcription:

Understanding Addiction KP Regional Pain Symposium August 8, 2011 Mary Eno MD, MPH Chief of Addiction Medicine SCPMG South Bay Understanding Addiction Why addicted patients baffle and overwhelm us Limbic (Reward) System of the Brain Rats & Levers & People Hedonic Tone Ways to define addiction Treatment & Outcomes Acknowledgements Ed Salsitz,, MD Beth-Isreal Medical Center, NY Eliot Gardner, PhD National Institute on Drug Abuse (NIDA) 1

Addiction in our practice Pulmonary--- ---Tobacco Addiction GI--- ---EtOH (Top Bottom), HCV, HBV Endo/Diabetes--- ---Food Obesity DM2 Infectious Disease--- ---IDU->HCV, HIV, infection ER--- ---Intoxication, OD, MVA & trauma Psychiatry--- ---Vulnerability/Co-morbidity Pediatrics--- ---Abuse, Adolescents Geriatrics--- ---Alcohol Mimics other diseases Why do people use drugs? Alter moods Escape negative feelings Promote & enhance social interactions Enhance pleasure & Sensation Enhance religious practice Explore the self Within the Limbic System The basic reward circuitry of the brain is a 3-neuron in-series synaptic circuit Descending Link ABN VTA, via Medial Forebrain Bundle Ascending Link VTA NAcc, via Medial Forebrain Bundle Further Ascending Link NAcc VP 2

3 Acc VTA FCX AMYG VP ABN Raphé LC GLU GABA ENK OPIOID GABA GABA GABA DYN 5HT 5HT 5HT NE HIPP PAG RETIC To dorsal horn END DA GLU Opiates ICSS Amphetamine Cocaine Opiates Cannabinoids Phencyclidine Ketamine Opiates Ethanol Barbiturates Benzodiazepines Nicotine Cannabinoids OPIOID HYPOTHAL LAT-TEG BNST NE CRF OFT The crucial reward The crucial reward neurotransmitter is neurotransmitter is dopamine (DA) dopamine (DA) Acc VTA FCX AMYG VP ABN Raphé LC GLU GABA ENK OPIOID GABA GABA GABA DYN 5HT 5HT 5HT NE HIPP PAG RETIC To dorsal horn END DA GLU Opiates ICSS Amphetamine Cocaine Opiates Cannabinoids Phencyclidine Ketamine Opiates Ethanol Barbiturates Benzodiazepines Nicotine Cannabinoids OPIOID HYPOTHAL LAT-TEG BNST NE CRF OFT

How we know this Stimulator Highly Aversive Consequences START LEVER Pump Pump Cocaine? 4

Progressive Ratio Breakpoint Progressively increases workload on the animal to get the next hit (1,2,4,8 lever presses required for injection) At some point, animal stops abruptly Rank-order drugs by breakpoint=human reports of addictivity Progressive Ratio Breakpoint diazepam 10:1 (Easy!) Morphine 200:1 Heroin 500:1 IV Cocaine >10,000 Presses:1 dose The common crucial reward neurotransmitter is dopamine (DA) 5

LIMBIC SYSTEM: Reward Center of the Brain Slide courtesy of Ed Salsitz, MD HEDONIC TONE Sense of wellbeing, happiness, pleasure, contentment Set by/in the mesolimbic dopaminergic circuitry Range: Euphoria Dysphoria Altered by Psychoactive Substances A Delicate Balance Life=weathering Low Hedonic Tone People vulnerable to addiction have low/abnormal tone What is Addiction? (a helpful description) An activity which initially provides pleasure, and is relatively harmless. In those who are vulnerable the use increases, the pleasure/hedonic tone decreases,, and the harm increases. 6

What is Addiction? (neuro-biology) An activity which initially stimulates the limbic system, which results in changes of neurotransmitter levels, which are perceived as euphoria or pleasure In the vulnerable, as the stimulation to the limbic and other parts of the brain continue, perturbations in brain function result in dysphoria, withdrawal, and impairments. Hedonic Tone Opioid Dependence (DSM-IV) (33 or more within one year) Tolerance Withdrawal Larger amounts/longer period than intended Inability to/persistent desire to cut down or control Increased amount of time spent in activities necessary to obtain substance Social, occupational and recreational activities given up or reduced Continued use despite adverse consequences WHAT IS ADDICTION? Physical Dependence Does Not Necessarily Equal Addiction 7

What is Addiction? (Primary Care perspective) A chronic, treatable, recurring disorder DM, HTN, asthma McClellan, Lewis, O Brien, O & Kleber. Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation JAMA Oct 4, 2000 Type I DM Compliance with: Medication <50% Diet and Foot Care <30% Re-treated within 12 months (ER or Hospital) 60-80% McLellen et al. (2000) Hypertension Compliance with: Medication <30% Diet <30% Re-treated within 12 months (ER or Hospital) 50-60% McLellen et al. (2000) 8

Asthma Compliance with: Medication <30% Re-treated within 12 months (ER or Hospital) 60-80% McLellen et al. (2000) Alcohol and Drug Dependence Abstinence one year after treatment: 40-60% completely abstinent 15-30% not completely abstinent but have not resumed dependency or problematic use McLellen et al. (2000) Compliance/Relapse Rates 100 90 80 70 60 50 40 30 20 10 0 Type I DM HTN Asthma Addiction 9

Addiction vulnerability Genetic Environmental Culture & Family Destitution Trauma Substance Availability Addiction History as taught Which drugs are you using How much, when last Age of onset for each drug Route of administration for each drug Previous treatment history Medical/Psych problems Other consequences Almost nothing about prior to addiction hx As though addiction fell from the sky. Addiction hx is the search for, and the understanding of the unique life circumstances affecting the patient s hedonic tone. 10

Addiction Medicine Office Supplies IS X POTENTIALLY ADDICTIVE? Must Activate the Limbic Circuit Tetracycline? Water Food Sex Exercise Alcohol Feelings 11

Tobacco Abuse: 1ppd x 20 years 10 200 1,400 Puffs/Cigarette Puffs/Day Puffs/Week 6,066 Puffs/Month 72,800 Puffs/Year 1,456,000 Puffs/20 years Photo courtesy of the NIDA Web site. From A Slide Teaching Packet: The Brain and the Actions of Cocaine, Opiates, and Marijuana. What is What is Addiction? (descriptive) Attempts to abstain from the activity are thwarted by cravings and prolonged withdrawal syndromes. Relapse is common, and often related to drug cues, stress, or drug exposure. Treatment is directed at improving mood state, functional status, and reversing or ameliorating harm that has occurred. This is done by stabilizing, improving and hopefully reversing the neurobiological perturbations secondary to the addictive agent, and the underlying vulnerability. 12

Project MATCH 1726 patients: 10 sites 2 arms: inpatient & outpatient rehab 3 therapies: CB, TSF, MET 12 wks therapy 1 yr follow-up Project MATCH Findings 60-80% reduction in: -Percent days abstinent -Drinks/drinking day TSF = 40% abstinent in 90 days prior to 15 mo FU CBT & MET = 36-38% 38% abstinent Difference significant but not large No interactions with psychiatric severity, ASPD, many others Project MATCH Conclusions Psychosocial treatments (counseling and psychotherapy) help Differences between therapies not large, when found Therapist effects can be significant 13

Medications for Opioid Dependence Methadone Naltrexone (ReVia, Vivitrol) Buprenorphine (Suboxone/Subutex) 14

Medications for Opioid Dependence Methadone (do not Rx for addiction!) Naltrexone (ReVia, Vivitrol) Clonidine (patch) Buprenorphine (Suboxone/Subutex) Buprenorphine High-affinity partial-mu-agonist Binds tightly to receptor, blocking opiates Displaces other opiates, can precipitate withdrawal Low abuse potential (Suboxone has naloxone deterrent) Few side effects but tricky to start Can Rx in the office (DEA X Required if not treating off-label for pain) Medication for Alcohol Dependence Disulfiram (Antabuse) Naltrexone (Revia( Revia,, Vivitrol) Acamprosate (Campral) Topiramate (Topamax)-Not FDA approved antidepressants only for co-occurring occurring depression, do NOT decrease drinking Good article: Williams, S. Medications for treating alcohol dependence. American Family Physician Nov 1, 2005. 72 (9):1775-80. 15

House staff Question Have You Ever Had A Hangover From Drinking Too Much Alcohol? What Did You Say To Yourself When You Were Hanging On To The Toilet Bowl? I ll Never Do That Again What Did You Do At The Next Party? Isn t That What Addicted People Do? Attending Question Do You Want To Lose Weight? What Did You Say To Yourself The Last Time You Ate Too Much? I m Going On A Diet, and Will Exercise How Is The Diet Going? How Much Weight Have You Lost? That s Why God Invented Statins Understanding yourself it s all about Hedonic Tone 16

Realistic Goals What You Can NOT Accomplish Cure the Addiction Problem Eliminate craving for the addictive agent Prevent relapse without ongoing treatment Realistic Goals What CAN be Accomplished Addiction is a chronic, relapsing, progressive brain disease, which can be treated, and put into remission Listening to the Story help both understand Brief Interventions (5-10 minutes) decrease smoking and problem drinking by 10-20% of patients Refer for addiction evaluation & treatment detox detox is not treatment These are challenging Cases For More Information www.samhsa.gov www.drugabuse.gov www.niaaa.nih.gov www.nida.nih.gov National Clearinghouse on Alcohol and Drug Information (NCADI): 1-800-729-6686 Many slides courtesy of NIDA, Ed Salsitz MD, and Eliot Gardner PhD 17